craft-sa-dev Home  

PMC:1448208 / 33664-33877 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
T20073 0-213 sentence denotes These neurologic symptoms may result from reduced levels of glutamate, glutamine, alanine, and other similar neuroactive amino acids, which are considered the culprit for MSUD encephalopathies in patients [1,37].
T20074 1-6 DT denotes These
T20076 7-17 JJ denotes neurologic
T20075 18-26 NNS denotes symptoms
T20078 27-30 MD denotes may
T20077 31-37 VB denotes result
T20079 38-42 IN denotes from
T20080 43-50 VBN denotes reduced
T20081 51-57 NNS denotes levels
T20082 58-60 IN denotes of
T20083 61-70 NN denotes glutamate
T20084 70-72 , denotes ,
T20085 72-81 NN denotes glutamine
T20086 81-83 , denotes ,
T20087 83-90 NN denotes alanine
T20088 90-92 , denotes ,
T20089 92-95 CC denotes and
T20090 96-101 JJ denotes other
T20092 102-109 JJ denotes similar
T20093 110-121 JJ denotes neuroactive
T20094 122-127 NN denotes amino
T20091 128-133 NNS denotes acids
T20095 133-135 , denotes ,
T20096 135-140 WDT denotes which
T20098 141-144 VBP denotes are
T20097 145-155 VBN denotes considered
T20099 156-159 DT denotes the
T20100 160-167 NN denotes culprit
T20101 168-171 IN denotes for
T20102 172-176 NN denotes MSUD
T20103 177-193 NNS denotes encephalopathies
T20104 194-196 IN denotes in
T20105 197-205 NNS denotes patients
T20106 206-207 -LRB- denotes [
T20108 207-208 CD denotes 1
T20109 208-209 , denotes ,
T20107 209-211 CD denotes 37
T20110 211-212 -RRB- denotes ]
T20111 212-213 . denotes .
R5192 T20074 T20075 det These,symptoms
R5193 T20075 T20077 nsubj symptoms,result
R5194 T20076 T20075 amod neurologic,symptoms
R5195 T20078 T20077 aux may,result
R5196 T20079 T20077 prep from,result
R5197 T20080 T20081 amod reduced,levels
R5198 T20081 T20079 pobj levels,from
R5199 T20082 T20081 prep of,levels
R5200 T20083 T20082 pobj glutamate,of
R5201 T20084 T20083 punct ", ",glutamate
R5202 T20085 T20083 conj glutamine,glutamate
R5203 T20086 T20085 punct ", ",glutamine
R5204 T20087 T20085 conj alanine,glutamine
R5205 T20088 T20087 punct ", ",alanine
R5206 T20089 T20087 cc and,alanine
R5207 T20090 T20091 amod other,acids
R5208 T20091 T20087 conj acids,alanine
R5209 T20092 T20091 amod similar,acids
R5210 T20093 T20091 amod neuroactive,acids
R5211 T20094 T20091 compound amino,acids
R5212 T20095 T20083 punct ", ",glutamate
R5213 T20096 T20097 dep which,considered
R5214 T20097 T20083 relcl considered,glutamate
R5215 T20098 T20097 auxpass are,considered
R5216 T20099 T20100 det the,culprit
R5217 T20100 T20097 oprd culprit,considered
R5218 T20101 T20100 prep for,culprit
R5219 T20102 T20103 compound MSUD,encephalopathies
R5220 T20103 T20101 pobj encephalopathies,for
R5221 T20104 T20100 prep in,culprit
R5222 T20105 T20104 pobj patients,in
R5223 T20106 T20107 punct [,37
R5224 T20107 T20077 parataxis 37,result
R5225 T20108 T20107 nummod 1,37
R5226 T20109 T20107 punct ",",37
R5227 T20110 T20107 punct ],37
R5228 T20111 T20077 punct .,result